The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Esa Jantunen

University of Eastern Finland/Clinical Medicine

Kuopio

Finland

[email]@kuh.fi

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • University of Eastern Finland/Clinical Medicine, Kuopio, Finland. 2010 - 2012
  • University of Eastern Finland, and Kuopio University Hospital, Department of Medicine, P.O.B. 1777. 2011
  • Department of Medicine, Kuopio University Hospital, Kuopio, Finland University of Eastern Finland/Institute of Clinical Medicine, Finland. 2011
  • Department of Medicine, Kuopio University Hospital, Kuopio, Finland. 2002 - 2008

References

  1. Kinetics of blood CD34(+) cells after chemotherapy plus G-CSF in poor mobilizers: implications for pre-emptive plerixafor use. Jantunen, E., Varmavuo, V., Juutilainen, A., Kuittinen, T., Mahlamäki, E., Mäntymaa, P., Nousiainen, T. Ann. Hematol. (2012) [Pubmed]
  2. Novel strategies for blood stem cell mobilization: special focus on plerixafor. Jantunen, E. Expert. Opin. Biol. Ther (2011) [Pubmed]
  3. Efficacy of pre-emptively used plerixafor in patients mobilizing poorly after chemomobilization: a single centre experience. Jantunen, E., Kuittinen, T., Mahlamäki, E., Pyörälä, M., Mäntymaa, P., Nousiainen, T. Eur. J. Haematol. (2011) [Pubmed]
  4. Mobilization strategies in hard-to-mobilize patients with lymphoid malignancies. Jantunen, E., Kvalheim, G. Eur. J. Haematol. (2010) [Pubmed]
  5. Changing landscape of invasive aspergillosis in allogeneic stem cell transplant recipients. Jantunen, E., Nihtinen, A., Anttila, V.J. Transpl. Infect. Dis (2008) [Pubmed]
  6. Blood stem cell mobilization and collection in patients with chronic lymphocytic leukaemia: a nationwide analysis. Jantunen, E., Itälä, M., Siitonen, T., Kuittinen, T., Heiskanen, J., Koivunen, E., Juvonen, E., Silvennoinen, R., Nousiainen, T., Koistinen, P., Volin, L., Remes, K. Bone Marrow Transplant. (2008) [Pubmed]
  7. Autologous stem cell transplantation in elderly patients (> or =60 years) with diffuse large B-cell lymphoma: an analysis based on data in the European Blood and Marrow Transplantation registry. Jantunen, E., Canals, C., Rambaldi, A., Ossenkoppele, G., Allione, B., Blaise, D., Conde, E., Tilly, H., Cook, G., Clark, F., Gallamini, A., Haynes, A., Mounier, N., Dreger, P., Pfreundschuh, M., Sureda, A. Haematologica (2008) [Pubmed]
  8. Blood stem cell mobilization and collection in patients with lymphoproliferative diseases: practical issues. Jantunen, E., Kuittinen, T. Eur. J. Haematol. (2008) [Pubmed]
  9. Autologous stem cell transplantation in elderly (>60 years) patients with non-Hodgkin's lymphoma: a nation-wide analysis. Jantunen, E., Itälä, M., Juvonen, E., Leppä, S., Keskinen, L., Vasala, K., Remes, K., Wiklund, T., Elonen, E., Nousiainen, T. Bone Marrow Transplant. (2006) [Pubmed]
  10. Early treatment-related mortality in adult autologous stem cell transplant recipients: a nation-wide survey of 1482 transplanted patients. Jantunen, E., Itälä, M., Lehtinen, T., Kuittinen, O., Koivunen, E., Leppä, S., Juvonen, E., Koistinen, P., Wiklund, T., Nousiainen, T., Remes, K., Volin, L. Eur. J. Haematol. (2006) [Pubmed]
  11. High-dose melphalan (200 mg/m2) supported by autologous stem cell transplantation is safe and effective in elderly (>or=65 years) myeloma patients: comparison with younger patients treated on the same protocol. Jantunen, E., Kuittinen, T., Penttilä, K., Lehtonen, P., Mahlamäki, E., Nousiainen, T. Bone Marrow Transplant. (2006) [Pubmed]
  12. Autologous stem cell transplantation in patients with chronic lymphocytic leukaemia: the Finnish experience. Jantunen, E., Itälä, M., Siitonen, T., Juvonen, E., Koivunen, E., Koistinen, P., Volin, L., Remes, K., Nousiainen, T. Bone Marrow Transplant. (2006) [Pubmed]
  13. Late non-relapse mortality among adult autologous stem cell transplant recipients: a nation-wide analysis of 1,482 patients transplanted in 1990-2003. Jantunen, E., Itälä, M., Siitonen, T., Koivunen, E., Leppä, S., Juvonen, E., Kuittinen, O., Lehtinen, T., Koistinen, P., Nyman, H., Nousiainen, T., Volin, L., Remes, K. Eur. J. Haematol. (2006) [Pubmed]
  14. Autologous stem cell transplantation beyond 60 years of age. Jantunen, E. Bone Marrow Transplant. (2006) [Pubmed]
  15. Autologous stem cell transplantation in patients with high-risk plasmacytoma. Jantunen, E., Koivunen, E., Putkonen, M., Siitonen, T., Juvonen, E., Nousiainen, T. Eur. J. Haematol. (2005) [Pubmed]
  16. Stem cell transplantation in autoimmune diseases: an update. Jantunen, E., Luosujärvi, R. Ann. Med. (2005) [Pubmed]
  17. Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey. Jantunen, E., Wiklund, T., Juvonen, E., Putkonen, M., Lehtinen, T., Kuittinen, O., Franssila, K., Söderström, K.O., Leppä, S., Elonen, E., Remes, K., Nousiainen, T. Bone Marrow Transplant. (2004) [Pubmed]
  18. Stem cell transplantation for peripheral T-cell lymphomas. Jantunen, E., D'Amore, F. Leuk. Lymphoma (2004) [Pubmed]
  19. Invasive fungal infections in autologous stem cell transplant recipients: a nation-wide study of 1188 transplanted patients. Jantunen, E., Salonen, J., Juvonen, E., Koivunen, E., Siitonen, T., Lehtinen, T., Kuittinen, O., Leppä, S., Anttila, V.J., Itälä, M., Wiklund, T., Remes, K., Nousiainen, T. Eur. J. Haematol. (2004) [Pubmed]
  20. Candidaemia in allogeneic stem cell transplant recipients: low risk without fluconazole prophylaxis. Jantunen, E., Nihtinen, A., Volin, L., Juvonen, E., Parkkali, T., Ruutu, T., Anttila, V.J. Bone Marrow Transplant. (2004) [Pubmed]
  21. Autologous stem cell transplantation in patients with primary amyloidosis: a nation-wide survey. Jantunen, E., Siitonen, T., Putkonen, M., Koivunen, E., Juvonen, E., Nousiainen, T., Koistinen, P. Leuk. Lymphoma (2004) [Pubmed]
  22. Multiple complete remissions in a patient with acute myeloid leukemia (M4eo) with low-dose cytosine arabinoside and all-trans retinoic acid. Jantunen, E., Mahlamäki, E., Heinonen, K., Nousiainen, T. Leuk. Lymphoma (2003) [Pubmed]
  23. BEAC or BEAM for high-dose therapy in patients with non-Hodgkin's lymphoma? A single centre analysis on toxicity and efficacy. Jantunen, E., Kuittinen, T., Nousiainen, T. Leuk. Lymphoma (2003) [Pubmed]
  24. Is chemotherapy scoring useful to predict progenitor cell mobilisation in patients with non-Hodgkin's lymphoma?. Jantunen, E., Kuittinen, T., Nousiainen, T. Bone Marrow Transplant. (2003) [Pubmed]
  25. Bisphosphonate therapy in multiple myeloma: past, present, future. Jantunen, E. Eur. J. Haematol. (2002) [Pubmed]
  26. A pilot study on feasibility and efficacy of amifostine preceding high-dose melphalan with autologous stem cell support in myeloma patients. Jantunen, E., Kuittinen, T., Nousiainen, T. Leuk. Lymphoma (2002) [Pubmed]
 
WikiGenes - Universities